Register Now!
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. Join us as we celebrate the State of Possible!
Founder & CEO, PanTher Therapeutics
Laura Indolfi is the Founder & CEO of PanTher Therapeutics, a spin-out of MIT and MGH that provides superior drug delivery technologies for revolutionizing the treatment of locally advanced solid tumors. Her scientific expertise covers a broad range of therapeutic areas (cardio, cancer, regenerative medicine) and approaches (drug delivery, cell therapy, implanted devices). Together with her strong technical background, Laura has hands-on business and managerial know-how developed during her biomedical business training at Sloan and Harvard Business schools, combining the science and business knowledges to drive the company’s vision. Prior to PanTher, she was a research associate at Harvard-MIT IMES, and served as entrepreneur-in-residence at MGH Cancer Center. She is a TED Fellow, one of 21 people chosen annually by the TED organization who are considered to be the most disruptive and transformative change-makers in the world. In 2017, she attended the prestigious conference “Fortune: Most Powerful Women – Next Gen”, an invite-only summit hosted by Fortune gathering a stellar group of game-changing executives, entrepreneurs and innovators. Laura is also one of the 5 women selected by Massachusetts Life Science Center and Takeda for their inaugural class in 2018 of MassNextGen program, honoring exceptional leaders in the biotech industry.

Brought to you by